The role of alginate dressings in wound healing and quality of life after pilonidal sinus resection: A randomised controlled trial

Int Wound J. 2022 Oct;19(6):1528-1538. doi: 10.1111/iwj.13752. Epub 2022 Jan 18.

Abstract

In this trial, we evaluated the role of alginate dressings in the secondary intention wound healing and quality of life (QoL) after pilonidal sinus resection. The study was designed as a prospective randomised controlled trial (RCT). In the experimental group, alginate dressings with silver and high-G cellulose were introduced after elective pilonidal cyst excision, whereas in the control group, simple gauges were used. The primary end point was the difference in terms of the wound healing period. Blinding existed at the level of the investigator. Overall, 65 patients were included during the study period. Wound healing duration was comparable between the two groups (P = .381). No difference in postoperative pain scores or recovery outcomes was found. The experimental group was associated with reduced wound secretions at specific time end points. Similarly, no effect was identified, on overall Wound-QoL or SF-36 scores. Alginate dressings do not accelerate wound healing or improve QoL. Due to suboptimal sample size and several study limitations, further RCTs are required to confirm our findings.

Keywords: alginate; cyst; dressings; pilonidal; quality.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Alginates / therapeutic use
  • Bandages
  • Cellulose
  • Humans
  • Pilonidal Sinus* / surgery
  • Quality of Life
  • Silver
  • Wound Healing

Substances

  • Alginates
  • Silver
  • Cellulose